1. Overview of genotoxic impurities in pharmaceutical development;Bercu;Int J. Toxicol.,2009
2. U.S.Food and Drug Administration, FDA Announces Voluntary Recall of Several Medicines Containing Valsartan Following Detection of an Impurity, (2020).www.fda.gov/newsevents/press-announcements/fda-announcesvoluntary-recall-several-medicines-containingvalsartan-following-detection-impurity.
3. U.S.Food and Drug Administration, Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan: Find out which Specific Blood Pressure Medications are Affected by the Recall, (2020).www.fda.gov/drugs/drug-safety-and-availability/search-list-recalled-angiotensin-ii-receptor-blockers-arbs-including-valsartan-losartan-and).
4. Critical analysis of drug product recalls due to nitrosamine impurities;Bharate;J. Med Chem.,2021
5. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data;Thresher;Regul. Toxicol. Pharm.,2020